查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年歐洲上游生物加工市場預測 - 區域分析 - 按產品類型、工作流程、使用類型和模式
市場調查報告書
商品編碼
1567871

2030 年歐洲上游生物加工市場預測 - 區域分析 - 按產品類型、工作流程、使用類型和模式

Europe Upstream Bioprocessing Market Forecast to 2030 - Regional analysis - by Product Type, Workflow, Usage Type, and Mode
出版日期: | 出版商: The Insight Partners | 英文 124 Pages | 訂單完成後即時交付

價格

2022年歐洲上游生物加工市場價值為25.8159億美元，預計2030年將達到70.6978億美元；預計2022年至2030年複合年成長率為13.4%。

生物製藥製造外包推動歐洲上游生物加工市場

大量合約開發和製造組織（CDMO）和合約製造組織（CMO）正在從事生物加工活動，這引發了這些設施對生物反應器的需求。透過生物製程進行藥品製造的策略性外包，使生物製藥公司能夠利用外部合作夥伴在上游流程中的專業知識和先進能力，促進獲得專業技術、流程最佳化專業知識和可擴展的製造能力。透過與 CDMO 和 CMO 合作，生物製藥公司可以有效管理製造需求，適應生產需求的波動，並專注於核心研發活動。此外，外包透過利用外部合作夥伴已建立的基礎設施和合規設施來提高成本效率並降低風險。外包生物加工功能使生物製藥公司能夠專注於促進創新、技術進步和整體上游製程擴展。因此，生物製藥製造的外包極大地推動了上游生物加工市場的成長。

歐洲上游生物加工市場概況

歐洲上游生物加工市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。由於政府和私人資金可用於生物製品和藥品研究，預計將出現強勁的成長率，從而推動創新技術的推出。該地區擁有各種組織和機構，透過會議和其他活動來監督製藥業的實踐。歐洲的公司一直致力於在各種活動中展示其產品，以便能夠加強其客戶群並收集有關該地區其他參與者的開發資訊。因此，研究計畫、創新產品和會議等活動有利於歐洲上游生物加工市場。

歐洲上游生物加工市場收入及 2030 年預測（百萬美元）

歐洲上游生物加工市場細分

歐洲上游生物加工市場根據產品類型、工作流程、使用類型、模式和國家進行細分。根據產品類型，歐洲上游生物加工市場分為生物反應器/發酵槽、細胞培養、過濾器、袋子和容器等。 2022 年，生物反應器/發酵器服務佔據最大的市場佔有率。

根據工作流程，歐洲上游生物加工市場分為培養基製備、細胞培養和細胞分離。 2022 年，細胞分離佔據最大的市場佔有率。

根據使用類型，歐洲上游生物加工市場分為一次性和多用途。 2022年一次性使用將佔據更大的市場佔有率

根據模式，歐洲上游生物加工市場分為內部和外包。 2022 年，In-house 佔據了更大的市場佔有率。

根據國家/地區，歐洲上游生物加工市場分為英國、德國、法國、義大利、西班牙和歐洲其他地區。 2022年，德國將主導歐洲上游生物加工市場佔有率。

Thermo Fisher Scientific Inc、Esco Micro Pte Ltd、Cellexus International Ltd、Sartorius AG、Getinge AB、Merck KGaA、Corning Inc 和 Entegris Inc 是歐洲上游生物加工市場的一些領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：歐洲上游生物加工市場格局

  • 概述
  • PEST分析

第 5 章：歐洲上游生物加工市場 - 主要市場動態

  • 市場促進因素
    • 一次性生物反應器的商業用途
    • 生物製藥製造外包
    • 醫藥和生技產業快速成長
  • 市場限制
    • 嚴格的規範架構
  • 市場機會
    • 技術進步
  • 未來趨勢
    • 加大生醫產業研發投入
  • 促進因素和限制的影響：

第 6 章：上游生物加工市場 - 歐洲分析

第 7 章：歐洲上游生物加工市場分析 - 按產品類型

  • 生物反應器/發酵罐
  • 細胞培養
  • 過濾器
  • 袋子和容器
  • 其他

第 8 章：歐洲上游生物加工市場分析 - 按工作流程

  • 媒體準備
  • 細胞培養
  • 細胞分離

第 9 章：歐洲上游生物加工市場分析 - 按使用類型

  • 一次使用
  • 多用途

第 10 章：歐洲上游生物加工市場分析 - 按模式

  • 內部
  • 外包

第 11 章：歐洲上游生物加工市場 - 國家分析

  • 歐洲市場概況
    • 歐洲
      • 英國
      • 德國
      • 法國
      • 義大利
      • 西班牙
      • 歐洲其他地區

第 12 章：產業格局

  • 概述
  • 上游生物加工市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 13 章：公司簡介

  • Thermo Fisher Scientific Inc
  • Esco Micro Pte Ltd
  • Cellexus International Ltd
  • Sartorius AG
  • Getinge AB
  • Merck KGaA
  • Corning Inc
  • Entegris Inc

第 14 章：附錄

Product Code: BMIRE00030684

The Europe upstream bioprocessing market was valued at US$ 2,581.59 million in 2022 and is expected to reach US$ 7,069.78 million by 2030; it is estimated to grow at a CAGR of 13.4% from 2022 to 2030.

Outsourcing of Biopharmaceutical Manufacturing Drives Europe Upstream Bioprocessing Market

A large number of contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs) are engaging in bioprocessing activities, which triggers the demand for bioreactors in these facilities. The strategic outsourcing of pharmaceutical manufacturing through bioprocessing allows biopharmaceutical companies to leverage external partners' expertise and advanced capabilities in upstream processes, facilitating access to specialized technologies, process optimization expertise, and scalable manufacturing capacity. By partnering with CDMOs and CMOs, biopharmaceutical firms can efficiently manage manufacturing needs, accommodate fluctuations in production demands, and focus on core research and development activities. Additionally, outsourcing offers cost efficiencies and risk mitigation by leveraging external partners' established infrastructure and regulatory-compliant facilities. Outsourcing the bioprocessing functions allows biopharmaceutical companies to focus on fostering innovation, technological advancements, and overall upstream process expansion. Thus, the outsourcing of biopharmaceutical manufacturing significantly drives the growth of the upstream bioprocessing market.

Europe Upstream Bioprocessing Market Overview

The Europe upstream bioprocessing market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. It is expected to register a robust growth rate owing to the availability of government and private funding for research in biologics and pharmaceuticals, leading to the launch of innovative technologies. The region has various organizations and bodies that monitor the practices being carried out in the pharmaceutical industry through conferences and other events. Companies in Europe have been focusing on showcasing their products at various events to be able to strengthen their customer base and collect information regarding developments made by any other players in the region. Thus, research initiatives, innovative products, and events such as conferences benefit the upstream bioprocessing market in Europe.

Europe Upstream Bioprocessing Market Revenue and Forecast to 2030 (US$ Million)

Europe Upstream Bioprocessing Market Segmentation

The Europe upstream bioprocessing market is segmented based on product type, workflow, usage type, mode, and country. Based on product type, the Europe upstream bioprocessing market is segmented into bioreactors/fermenters, cell culture, filters, bags and containers, and others. The bioreactors/fermenters services held the largest market share in 2022.

Based on workflow, the Europe upstream bioprocessing market is categorized into media preparation, cell culture, and cell separation. The cell separation held the largest market share in 2022.

Based on usage type, the Europe upstream bioprocessing market is bifurcated into single-use and multi-use. The single-use held a larger market share in 2022

Based on mode, the Europe upstream bioprocessing market is bifurcated into In-house and outsourced. The In-house held a larger market share in 2022.

Based on country, the Europe upstream bioprocessing market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe upstream bioprocessing market share in 2022.

Thermo Fisher Scientific Inc, Esco Micro Pte Ltd, Cellexus International Ltd, Sartorius AG, Getinge AB, Merck KGaA, Corning Inc, and Entegris Inc are some of the leading companies operating in the Europe upstream bioprocessing market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Upstream Bioprocessing Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Europe Upstream Bioprocessing Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Commercial Use of Single-Use Bioreactors
    • 5.1.2 Outsourcing of Biopharmaceutical Manufacturing
    • 5.1.3 Rapid Growth of Pharmaceutical and Biotechnology Industries
  • 5.2 Market Restraints
    • 5.2.1 Stringent Regulatory Framework
  • 5.3 Market Opportunities
    • 5.3.1 Technological Advancements
  • 5.4 Future Trends
    • 5.4.1 Increasing Investments in R&D in Biopharmaceutical Industry
  • 5.5 Impact of Drivers and Restraints:

6. Upstream Bioprocessing Market - Europe Analysis

7. Europe Upstream Bioprocessing Market Analysis - by Product Type

  • 7.1 Bioreactors/Fermenters
    • 7.1.1 Overview
    • 7.1.2 Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Cell Culture
    • 7.2.1 Overview
    • 7.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Filters
    • 7.3.1 Overview
    • 7.3.2 Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Bags and Containers
    • 7.4.1 Overview
    • 7.4.2 Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Upstream Bioprocessing Market Analysis - by Workflow

  • 8.1 Media Preparation
    • 8.1.1 Overview
    • 8.1.2 Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Cell Culture
    • 8.2.1 Overview
    • 8.2.2 Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Cell Separation
    • 8.3.1 Overview
    • 8.3.2 Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Upstream Bioprocessing Market Analysis - by Usage Type

  • 9.1 Single-use
    • 9.1.1 Overview
    • 9.1.2 Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Multi-use
    • 9.2.1 Overview
    • 9.2.2 Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Upstream Bioprocessing Market Analysis - by Mode

  • 10.1 In-house
    • 10.1.1 Overview
    • 10.1.2 In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Outsourced
    • 10.2.1 Overview
    • 10.2.2 Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Upstream Bioprocessing Market - Country Analysis

  • 11.1 Europe Market Overview
    • 11.1.1 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 Europe: Upstream Bioprocessing Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.2 UK
      • 11.1.1.3 UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.1 UK: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.3.2 UK: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.3.3 UK: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.3.4 UK: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.4 Germany
      • 11.1.1.5 Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.5.1 Germany: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.5.2 Germany: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.5.3 Germany: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.5.4 Germany: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.6 France
      • 11.1.1.7 France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.7.1 France: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.7.2 France: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.7.3 France: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.7.4 France: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.8 Italy
      • 11.1.1.9 Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.9.1 Italy: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.9.2 Italy: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.9.3 Italy: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.9.4 Italy: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.10 Spain
      • 11.1.1.11 Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.11.1 Spain: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.11.2 Spain: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.11.3 Spain: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.11.4 Spain: Upstream Bioprocessing Market Breakdown, by Mode
      • 11.1.1.12 Rest of Europe
      • 11.1.1.13 Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.13.1 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Product Type
        • 11.1.1.13.2 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Workflow
        • 11.1.1.13.3 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Usage Type
        • 11.1.1.13.4 Rest of Europe: Upstream Bioprocessing Market Breakdown, by Mode

12. Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Upstream Bioprocessing Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Thermo Fisher Scientific Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Esco Micro Pte Ltd
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Cellexus International Ltd
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Sartorius AG
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Getinge AB
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Merck KGaA
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Corning Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Entegris Inc
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Upstream Bioprocessing Market Segmentation
  • Table 2. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 3. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 4. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 5. Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 6. Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Country
  • Table 7. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 8. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 9. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 10. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 11. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 12. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 13. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 14. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 15. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 16. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 17. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 18. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 19. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 20. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 21. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 22. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 23. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 24. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 25. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 26. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 27. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Product Type
  • Table 28. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Workflow
  • Table 29. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Usage Type
  • Table 30. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million) - by Mode
  • Table 31. Recent Organic Growth Strategies in Upstream Bioprocessing Market
  • Table 32. Recent Inorganic Growth Strategies in the Upstream Bioprocessing Market
  • Table 33. Glossary of Terms, Upstream Bioprocessing Market

List Of Figures

  • Figure 1. Upstream Bioprocessing Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Europe Upstream Bioprocessing Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Upstream Bioprocessing Market Revenue (US$ Million), 2020-2030
  • Figure 6. Upstream Bioprocessing Market Share (%) - by Product Type (2022 and 2030)
  • Figure 7. Bioreactors/Fermenters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Filters: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Bags and Containers: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Upstream Bioprocessing Market Share (%) - by Workflow (2022 and 2030)
  • Figure 13. Media Preparation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Cell Culture: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Cell Separation: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Upstream Bioprocessing Market Share (%) - by Usage Type (2022 and 2030)
  • Figure 17. Single-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Multi-use: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Upstream Bioprocessing Market Share (%) - by Mode (2022 and 2030)
  • Figure 20. In-house: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Outsourced: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Europe: Upstream Bioprocessing Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 23. Europe: Upstream Bioprocessing Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 24. UK: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Germany: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. France: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Italy: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Spain: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Rest of Europe: Upstream Bioprocessing Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Growth Strategies in Upstream Bioprocessing Market